Shiv Saidha, MD
Enriched profileAssociate Professor of Neurology, Division of Neuroimmunology & Neurological Infections · Johns Hopkins University School of Medicine
Shiv Saidha is Associate Professor of Neurology, Division of Neuroimmunology & Neurological Infections at Johns Hopkins University School of Medicine. OpenAlex indexes 240 publications with 9,436 citations (h-index 50); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 12 Oct 2026
Overview
Updated 16 Oct 2026
Shiv Saidha, MBBCH, is Associate Professor of Neurology, Division of Neuroimmunology & Neurological Infections at Johns Hopkins University School of Medicine. The public record shows 240 publications with 9,436 citations (h-index 50), centered on Multiple Sclerosis Research Studies, Glaucoma and retinal disorders, Drug-Induced Ocular Toxicity. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 15 companies, 1 NIH-funded awards (2024–2026).
- Most recent indexed publication: 2026 · Brain communications
- Top research focus: Multiple Sclerosis Research Studies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 127.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
Sponsor: Johns Hopkins University
- Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Sponsor: Johns Hopkins University
- An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
Sponsor: LAPIX Therapeutics Inc.
Industry payments
Updated 16 Oct 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year202541 payments$36,169openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20257 payments$24,161openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
72.8%SNRI17.5%Duloxetine Hcl73%Venlafaxine Hcl Er27%Part D<11 patientsGabapentinoids16.9%Gabapentin100%Part D≥20 patients+ 5 more classes in this area
Musculoskeletal
16.4%gamma-Aminobutyric Acid-ergic Agonist16.4%Baclofen100%Part D≥15 patientsCancer & immunology
10.8%CD20-directed Cytolytic Antibody4.4%Kesimpta Pen100%Part D<11 patientsOther immunostimulants3.3%Copaxone100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Autologous haematopoietic stem cell transplantation stabilizes retinal atrophy in multiple sclerosis.
Brain communications
Article2026 - Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.
Multiple sclerosis journal - experimental, translational and clinical
Article2026 - Retinal atrophy in multiple sclerosis is similar with extended versus standard interval natalizumab therapy.
Multiple sclerosis journal - experimental, translational and clinical
Article2026 - Association of epiretinal membranes with disability in people with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026
Most-cited works
by citation count (OpenAlex)- 01Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysisReview583 citations2017
- 02Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaArticle461 citations2025
- 03The APOSTEL recommendations for reporting quantitative optical coherence tomography studiesArticle416 citations2016
- 04Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year studyArticle391 citations2015
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
practicalneurology.com/profiles/shiv-saidha-mbbch/j1DNPG/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →practicalneurology.com ↗ - Other
globalneurologyacademy.org/profiles/shiv-saidha-mbbch-md-mrcpi/j1DNPG/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalneurologyacademy.org ↗ - Other
hopkinsmedicine.org/profiles/details/shiv-saidha
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →practicalneurology.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →practicalneurology.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalneurologyacademy.org ↗
Secondary affiliations
appointments beyond the home institution- Faculty member
Global Neurology Academy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalneurologyacademy.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida